Published in Women's Health Weekly, June 7th, 2001
Sachiko Matsuzaki and coworkers at Tohoku University School of Medicine in Japan have found women with endometriosis have greater levels of the protein erythropoietin in their peritoneal fluid as compared with women without endometriosis. Because erythropoietin may influence the early development of endometriosis, drugs designed to inhibit peritoneal erythropoietin levels could, potentially, be used for treating the initial stages of the disease.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly